Strong growth for nutraceuticals group

- Last updated on GMT

Related tags: Marketing

Australian manufacturer of pharmaceuticals and nutraceuticals FH
Faulding announced this week a net profit of AU$ 106 million.

Australian manufacturer of pharmaceuticals and nutraceuticals FH Faulding announced this week a net profit of AU$ 106 million (Euro61.9m), a rise of 35.4 per cent from last year. The company said in a statement that the results were helped by a particularly strong performance in the pharmaceutical division which showed a closing balance of AU$ 279 million (Euro162.9m) in June 2001 compared to AU$ 203 million (Euro118.5m) in 2000. The nutraceutical market witnessed a depression in sales with growth of only 3.6 per cent. But FH Faulding​ stated that moves to integrate the supply chain for the vitamins, minerals and supplements (VMS) business ensured that significant cost savings were realised.

Related topics: Suppliers

Follow us

Featured Events

View more

Products

View more

Webinars